HealthQuad Invests in LifeSigns to Expand AI-Based Remote Patient Monitoring Platform

The investment will also be used to strengthen LifeSigns’ predictive care technology stack through selective AI integrations, according to the companies.

HealthQuad has announced an investment in LifeSigns to support the expansion of its AI-powered remote patient monitoring platform across Southeast Asia and Gulf Cooperation Council (GCC) markets.

The investment will also be used to strengthen LifeSigns’ predictive care technology stack through selective AI integrations, according to the companies.

HealthQuad, the healthcare-focused venture platform of Quadria Group, said the investment aligns with its strategy of supporting technologies that shift healthcare delivery from episodic care to continuous monitoring and predictive intelligence.

LifeSigns has developed a US FDA-approved remote patient monitoring platform that combines wearable devices, a cloud-based dashboard, and an AI engine designed to detect early signs of patient deterioration.

The platform currently operates across ambulances, emergency rooms, intensive care units, hospital wards, and home care settings. It monitors key parameters including ECG, heart rate, respiration, blood pressure, oxygen saturation, and temperature.

According to the company, its AI engine can identify signs of deterioration up to 26 hours in advance and detect critical risk within a four-hour window.

LifeSigns said the platform has been deployed across more than 50 hospitals in India, where it has generated over 87,000 alerts. The company also reported nearly 90% reduction in code blue incidents and a close to 78% decline in ICU readmissions across deployments.

The company follows an occupancy-based pricing model and has focused deployments beyond metropolitan areas, including tier 2 cities. It also operates a centralized monitoring command center for remote surveillance and operational management.

HealthQuad said the investment marks its first institutional backing of LifeSigns and will provide access to Quadria’s healthcare ecosystem to support global market expansion.

“Healthcare today is built on periodic observation while risk is real-time,” said Rahul Agarwal, commenting on the investment. He added that continuous monitoring and predictive intelligence are becoming increasingly important as healthcare systems face workforce shortages, rising costs, and growing patient demand.

LifeSigns founder Hari Subramaniam said the company aims to make predictive care a standard part of healthcare delivery and expand its model internationally with the support of HealthQuad and Quadria.

The global remote patient monitoring devices market is estimated at $26 billion in 2025, driven by increasing adoption of decentralized and continuous care models.

Stay tuned for more such updates on Digital Health News